| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AIMMUNE THERAPEUTICS INC COM | 4,087,900 | 75,422,000 | 25.29% | ||
| 2 | ADURO BIOTECH | 1,656,994 | 46,628,000 | 15.63% | ||
| 3 | ADAPTIMMUNE THERAPEUTICS PLC | 1,761,567 | 21,244,000 | 7.12% | ||
| 4 | UNIVERSAL AMERN CORP NEW | 2,814,883 | 19,704,000 | 6.61% | ||
| 5 | EPIZYME INC COM | 1,159,795 | 18,580,000 | 6.23% | ||
| 6 | AERIE PHARMACEUTICALS INC | 738,361 | 17,979,000 | 6.03% | ||
| 7 | REGULUS THERAPEUTICS INC | 1,750,669 | 15,266,000 | 5.12% | ||
| 8 | ALDER BIOPHARMACEUTICALS INC | 419,997 | 13,873,000 | 4.65% | ||
| 9 | Orexigen Therapeutics, Inc. | 6,225,049 | 10,707,000 | 3.59% | ||
| 10 | ZAFGEN INC COM | 1,488,410 | 9,362,000 | 3.14% | ||
| 11 | ARDELYX INC COM | 478,297 | 8,667,000 | 2.91% | ||
| 12 | NANOSTRING TECHNOLOGIES INC | 489,486 | 7,200,000 | 2.41% | ||
| 13 | ACCELERON PHARMA | 137,458 | 6,702,000 | 2.25% | ||
| 14 | BioDelivery Sciences International Inc | 947,815 | 4,540,000 | 1.52% | ||
| 15 | Anacor Pharmaceuticals Inc | 31,000 | 3,502,000 | 1.17% | Put | |
| 16 | Anacor Pharmaceuticals Inc | 31,000 | 3,502,000 | 1.17% | Call | |
| 17 | QUOTIENT LTD | 192,158 | 3,075,000 | 1.03% | ||
| 18 | NEXVET BIOPHARMA PUB LTD CO | 874,001 | 2,980,000 | 1.00% | ||
| 19 | REGENXBIO INC COM | 156,741 | 2,602,000 | 0.87% | ||
| 20 | SCYNEXIS INC | 337,177 | 2,094,000 | 0.70% | ||
| 21 | BioDelivery Sciences International Inc | 310,000 | 1,485,000 | 0.50% | Call | |
| 22 | AXOVANT SCIENCES LTD | 65,000 | 1,172,000 | 0.39% | ||
| 23 | BioDelivery Sciences International Inc | 210,000 | 1,006,000 | 0.34% | Put | |
| 24 | NEURODERM LTD | 55,779 | 951,000 | 0.32% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-081039, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
